DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma
Clinical trial NCT03837873 · UNKNOWN
Trial details
- NCT number
- NCT03837873
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-21
- Primary completion
- 2023-09-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.